FIELD: medicine.
SUBSTANCE: invention relates to medical diagnostics and monitoring of medicinal agents and concerns method of measuring of combined activity of blood coagulation factors II and X for control of anticoagulant therapy and kit for implementation of this method. Method involves mixing of analyzed human plasma, undergoing analysis, with specially prepared plasma with deficiency in blood coagulation factors II and X at ratio of analyzed plasma sample and deficiency plasma from 1:1 to 1:20; addition of coagulation reagent and calcium to analyzed sample; determination of blood ability of coagulation. Kits of invention include coagulation reagent, calcium and specially prepared plasma with deficiency in factor II and factor FX. Kit components are accordingly lyophilized.
EFFECT: invention provides more accurate assessment of blood coagulation ability.
16 cl, 4 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING BLOOD CLOTTING FACTOR DEFICIENCY BY THROMBOELASTOMETRY | 2019 |
|
RU2699798C1 |
| FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS | 2011 |
|
RU2606155C2 |
| METHOD FOR DETERMINATION OF ACTIVATED FACTOR VII IN BLOOD PLASMA | 1991 |
|
RU2034298C1 |
| MODIFIED FACTOR VII-BASED POLYPEPTIDES AND THEREOF APPLICATION | 2008 |
|
RU2571931C2 |
| METHOD OF PRODUCING THROMBIN CONCENTRATE | 2014 |
|
RU2583931C2 |
| PHOSPHOLIPID-ENRICHED VESICLES BEARING TISSUE FACTOR HAVING HAEMOSTATIC ACTIVITY AND USE THEREOF | 2011 |
|
RU2595406C2 |
| DETERMINATION OF INTERNATIONAL NORMALIZED RATIO (INR) BASED ON CAPILLARY BLOOD PROTHROMBIN TIME (PT) | 2005 |
|
RU2271004C1 |
| METHOD FOR OBTAINING A LIOPHILIZED PREPARATION OF AN ACTIVATED PROTROMBIN COMPLEX HAVING VIII-SHUNTING ACTIVITY FACTOR | 2017 |
|
RU2648517C1 |
| METHOD OF OBTAINING VIRUS-SAFE COMPLETE PROTHROMBIN COMPLEX | 2014 |
|
RU2559576C1 |
| METHOD FOR PREDICTING ANTIPHOSPHOLIPID SYNDROME | 2003 |
|
RU2254572C2 |
